Connect your AI

Biogen BIIB ADUHELM — Decrease in unrecognized tax benefits is reasonably possible

Discontinued — last reported Q3 '23

Similar metrics at other companies

JEFDecrease in Unrecognized Tax Benefits is Reasonably Possible

$36.4M+22.1%

RJFDecrease in Unrecognized Tax Benefits is Reasonably Possible

$11M-45.0%

GEVChanges in unrecognized tax benefits

$80.75M+420%

LYBChanges in unrecognized tax benefits

$1.25M-72.2%

DECKChanges in unrecognized tax benefits

$2.93M—

MMMChanges in unrecognized tax benefits

-$12.5M—

Other financials

Income statement

Revenue$2.5B+1.9%

Gross profit$1.8B+0.8%

Operating income$610.7M—

Net income$319.5M+32.8%

EPS (diluted)$2.15+31.1%

Balance sheet

Cash & equivalents$3.4B+30.2%

Total debt$6.6B+34.7%

Total equity$18.7B+9.9%

Total assets$29.5B+5.2%

Cash flow

Operating cash flow$645.5M+149%

CapEx$51.2M+38.0%

Free cash flow$594.3M+167%

Valuation

Market cap$29.02B+34.3%

Enterprise value$32.2B+34.9%

P/E20.4×+5.8×

P/S2.9×+0.7×

Profitability

Gross margin75.5%-0.1pp

Operating margin22.9%—

Net margin14.3%-0.8pp

FCF margin24.4%-0.4pp

Returns & leverage

Return on equity8%-1.2pp

Debt / equity0.4×+0.1×

Current ratio3.1×+1.6×

Where this comes from

Reported directly by Biogen in its filing.

Tagged under the XBRL concept us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible.

The official record: Biogen’s 10-Q, filed November 8, 2023, on SEC EDGAR. View the filing →

Ask your AI about Biogen's aduhelm — decrease in unrecognized tax benefits is reasonably possible.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Biogen's ADUHELM — decrease in unrecognized tax benefits is reasonably possible?: Biogen (BIIB) reported ADUHELM — decrease in unrecognized tax benefits is reasonably possible of $450M in Q3 2023.